DAVE250117C155000
- 0.00
- 0.000.00%
Dave Inc Newsroom
Institutional Investors in Dave Inc. (NASDAQ:DAVE) Lost 8.1% Last Week but Have Reaped the Benefits of Longer-term Growth
8 Analysts Have This To Say About Dave
Dave Price Target Maintained With a $119.00/Share by Benchmark
Dave Analyst Ratings
Benchmark Co. Maintains Dave Inc(DAVE.US) With Buy Rating, Maintains Target Price $119
Benchmark Co. Remains a Buy on Dave (DAVE)
Is DAVE INC (DAVE) Outperforming Other Business Services Stocks This Year?
Sector Update: Financial Stocks Mixed Tuesday Afternoon
Top Midday Decliners
Top Midday Stories: Sangamo Shares Fall After Pfizer Exits Collaboration; Dave Denies DOJ Allegations
Lake Street Maintains Dave Inc(DAVE.US) With Buy Rating, Maintains Target Price $98
Sector Update: Tech Stocks Advance Premarket Tuesday
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Ahead of Last Trading Day of 2024
Sangamo Therapeutics, Dave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Sector Update: Tech
Dave Denies Wrongdoing in DOJ Complaint
Dave Explains FTC Complaint Amendment; Changes ExtraCash Fee Structure
Express News | Dave Shares Down 7.3% Premarket After U.S. Justice Department Files Complaint Against Co and CEO
Express News | Dave Inc. Says Company's Outlook Remains Positive, And It Looks Forward To Sharing Results And More Substantive Update During Q4 Earnings Call In Early March
Express News | Dave Inc: Expects to Complete Full Implementation of New Fee Structure in Early 2025